<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37269008</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>02</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>X-linked SBMA model mice display relevant non-neurological phenotypes and their expression of mutant androgen receptor protein in motor neurons is not required for neuromuscular disease.</ArticleTitle><Pagination><StartPage>90</StartPage><MedlinePgn>90</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">90</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-023-01582-1</ELocationID><Abstract><AbstractText>X-linked spinal and bulbar muscular atrophy (SBMA; Kennedy's disease) is a rare neuromuscular disorder characterized by adult-onset proximal muscle weakness and lower motor neuron degeneration. SBMA was the first human disease found to be caused by a repeat expansion mutation, as affected patients possess an expanded tract of CAG repeats, encoding polyglutamine, in the androgen receptor (AR) gene. We previously developed a conditional BAC fxAR121 transgenic mouse model of SBMA and used it to define a primary role for skeletal muscle expression of polyglutamine-expanded AR in causing the motor neuron degeneration. Here we sought to extend our understanding of SBMA disease pathophysiology and cellular basis by detailed examination and directed experimentation with the BAC fxAR121 mice. First, we evaluated BAC fxAR121 mice for non-neurological disease phenotypes recently described in human SBMA patients, and documented prominent non-alcoholic fatty liver disease, cardiomegaly, and ventricular heart wall thinning in aged male BAC fxAR121 mice. Our discovery of significant hepatic and cardiac abnormalities in SBMA mice underscores the need to evaluate human SBMA patients for signs of liver and heart disease. To directly examine the contribution of motor neuron-expressed polyQ-AR protein to SBMA neurodegeneration, we crossed BAC fxAR121 mice with two different lines of transgenic mice expressing Cre recombinase in motor neurons, and after updating characterization of SBMA phenotypes in our current BAC fxAR121 colony, we found that excision of mutant AR from motor neurons did not rescue neuromuscular or systemic disease. These findings further validate a primary role for skeletal muscle as the driver of SBMA motor neuronopathy and indicate that therapies being developed to treat patients should be delivered peripherally.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gromova</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departments of Pathology and Laboratory Medicine, Neurology, and Biological Chemistry, University of California Irvine, Irvine, CA, 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cha</LastName><ForeName>Byeonggu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Departments of Pathology and Laboratory Medicine, Neurology, and Biological Chemistry, University of California Irvine, Irvine, CA, 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Erica M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Duke University, Durham, NC, 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strickland</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Pediatrics, Duke University, Durham, NC, 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Nhat</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Departments of Pathology and Laboratory Medicine, Neurology, and Biological Chemistry, University of California Irvine, Irvine, CA, 92697, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>ElMallah</LastName><ForeName>Mai K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Pediatrics, Duke University, Durham, NC, 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortes</LastName><ForeName>Constanza J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>School of Gerontology, University of Southern California, Los Angeles, CA, 90089, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Spada</LastName><ForeName>Albert R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0001-6151-2964</Identifier><AffiliationInfo><Affiliation>Departments of Pathology and Laboratory Medicine, Neurology, and Biological Chemistry, University of California Irvine, Irvine, CA, 92697, USA. alaspada@uci.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Chemistry, University of California Irvine, Irvine, CA, 92697, USA. alaspada@uci.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCI Institute for Neurotherapeutics, University of California Irvine, Irvine, CA, 92697, USA. alaspada@uci.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 NS122140</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS100023</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>3</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37269008</ArticleId><ArticleId IdType="pmc">PMC10239133</ArticleId><ArticleId IdType="doi">10.1186/s40478-023-01582-1</ArticleId><ArticleId IdType="pii">10.1186/s40478-023-01582-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18(7):671&#x2013;680. doi: 10.1212/WNL.18.7.671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.18.7.671</ArticleId><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77&#x2013;79. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunting EL, Hamilton J, Tabrizi SJ. Polyglutamine diseases. Curr Opin Neurobiol. 2022;72:39&#x2013;47. doi: 10.1016/j.conb.2021.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2021.07.001</ArticleId><ArticleId IdType="pubmed">34488036</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron. 2014;82(2):295&#x2013;307. doi: 10.1016/j.neuron.2014.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.03.001</ArticleId><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 2014;7(3):774&#x2013;784. doi: 10.1016/j.celrep.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Guber RD, et al. Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy. Neurology. 2017;89(24):2481&#x2013;2490. doi: 10.1212/WNL.0000000000004748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004748</ArticleId><ArticleId IdType="pmc">PMC5729799</ArticleId><ArticleId IdType="pubmed">29142082</ArticleId></ArticleIdList></Reference><Reference><Citation>Francini-Pesenti F, et al. Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of Italian patients with spinal-bulbar muscular atrophy. Acta Myol. 2018;37(3):204&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6390113</ArticleId><ArticleId IdType="pubmed">30838350</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki A, et al. Brugada syndrome in spinal and bulbar muscular atrophy. Neurology. 2014;82(20):1813&#x2013;1821. doi: 10.1212/WNL.0000000000000434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000434</ArticleId><ArticleId IdType="pubmed">24759840</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmetz K, et al. J wave syndromes in patients with spinal and bulbar muscular atrophy. J Neurol. 2022;269(7):3690&#x2013;3699. doi: 10.1007/s00415-022-10992-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-10992-5</ArticleId><ArticleId IdType="pmc">PMC9217903</ArticleId><ArticleId IdType="pubmed">35132468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopher BL, La Spada AR. Efficient recombination-based methods for bacterial artificial chromosome fusion and mutagenesis. Gene. 2006;371(1):136&#x2013;143. doi: 10.1016/j.gene.2005.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2005.11.034</ArticleId><ArticleId IdType="pubmed">16487669</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, et al. Mitotic and meiotic stability of the CAG repeat in the X-linked spinal and bulbar muscular atrophy gene. Clin Genet. 1996;50(3):133&#x2013;137. doi: 10.1111/j.1399-0004.1996.tb02367.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.1996.tb02367.x</ArticleId><ArticleId IdType="pubmed">8946111</ArticleId></ArticleIdList></Reference><Reference><Citation>Henikoff S. Conspiracy of silence among repeated transgenes. BioEssays. 1998;20(7):532&#x2013;535. doi: 10.1002/(SICI)1521-1878(199807)20:7&lt;532::AID-BIES3&gt;3.0.CO;2-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1521-1878(199807)20:7&lt;532::AID-BIES3&gt;3.0.CO;2-M</ArticleId><ArticleId IdType="pubmed">9723001</ArticleId></ArticleIdList></Reference><Reference><Citation>Haruyama N, Cho A, Kulkarni AB. Overview: engineering transgenic constructs and mice. Curr Protoc Cell Biol. 2009;42:10&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743315</ArticleId><ArticleId IdType="pubmed">19283728</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera A, et al. The sound of silence: transgene silencing in mammalian cell engineering. Cell Syst. 2022;13(12):950&#x2013;973. doi: 10.1016/j.cels.2022.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2022.11.005</ArticleId><ArticleId IdType="pmc">PMC9880859</ArticleId><ArticleId IdType="pubmed">36549273</ArticleId></ArticleIdList></Reference><Reference><Citation>Misawa H, et al. VAChT-Cre. Fast and VAChT-Cre.Slow: postnatal expression of Cre recombinase in somatomotor neurons with different onset. Genesis. 2003;37(1):44&#x2013;50. doi: 10.1002/gene.10224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gene.10224</ArticleId><ArticleId IdType="pubmed">14502577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditsworth D, et al. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133(6):907&#x2013;922. doi: 10.1007/s00401-017-1698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1698-6</ArticleId><ArticleId IdType="pmc">PMC5427168</ArticleId><ArticleId IdType="pubmed">28357566</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, et al. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron. 2001;30(2):399&#x2013;410. doi: 10.1016/S0896-6273(01)00287-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00287-2</ArticleId><ArticleId IdType="pubmed">11395002</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, et al. Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. Nat Genet. 1999;23(1):67&#x2013;70. doi: 10.1038/12669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/12669</ArticleId><ArticleId IdType="pubmed">10471501</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejager S, et al. A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab. 2002;87(8):3893&#x2013;3901.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161529</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, et al. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A. 2007;104(46):18259&#x2013;18264. doi: 10.1073/pnas.0705501104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705501104</ArticleId><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehky TJ, et al. Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy. Muscle Nerve. 2009;40(5):809&#x2013;814. doi: 10.1002/mus.21399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21399</ArticleId><ArticleId IdType="pmc">PMC2763967</ArticleId><ArticleId IdType="pubmed">19670325</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes LE, et al. Clinical features of spinal and bulbar muscular atrophy. Brain. 2009;132(Pt 12):3242&#x2013;3251. doi: 10.1093/brain/awp258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="pubmed">19846582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi V, et al. Plasma pNfH levels differentiate SBMA from ALS. J Neurol Neurosurg Psychiatry. 2020;91(2):215&#x2013;217. doi: 10.1136/jnnp-2019-320624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320624</ArticleId><ArticleId IdType="pubmed">31575607</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkaslasi MR, et al. Single nucleus RNA-sequencing defines unexpected diversity of cholinergic neuron types in the adult mouse spinal cord. Nat Commun. 2021;12(1):2471. doi: 10.1038/s41467-021-22691-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22691-2</ArticleId><ArticleId IdType="pmc">PMC8087807</ArticleId><ArticleId IdType="pubmed">33931636</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum JA, et al. Single-cell transcriptomic analysis of the adult mouse spinal cord reveals molecular diversity of autonomic and skeletal motor neurons. Nat Neurosci. 2021;24(4):572&#x2013;583. doi: 10.1038/s41593-020-00795-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00795-0</ArticleId><ArticleId IdType="pmc">PMC8016743</ArticleId><ArticleId IdType="pubmed">33589834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav A, et al. A cellular taxonomy of the adult human spinal cord. Neuron. 2023;111(3):328&#x2013;344. doi: 10.1016/j.neuron.2023.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.01.007</ArticleId><ArticleId IdType="pmc">PMC10044516</ArticleId><ArticleId IdType="pubmed">36731429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi V, et al. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology. 2019;92(11):e1205&#x2013;e1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511101</ArticleId><ArticleId IdType="pubmed">30787165</ArticleId></ArticleIdList></Reference><Reference><Citation>Shieh V, et al. Safety and tolerability of strength training in spinal and bulbar muscular atrophy: a case report. J Rehabil Med Clin Commun. 2022;5:2513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9422881</ArticleId><ArticleId IdType="pubmed">36072267</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, et al. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. Lancet Neurol. 2018;17(12):1043&#x2013;1052. doi: 10.1016/S1474-4422(18)30320-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30320-X</ArticleId><ArticleId IdType="pmc">PMC6415539</ArticleId><ArticleId IdType="pubmed">30337273</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, et al. No evidence of cardiomyopathy in spinal and bulbar muscular atrophy. Acta Neurol Scand. 2013;128(6):e30&#x2013;e32. doi: 10.1111/ane.12140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12140</ArticleId><ArticleId IdType="pubmed">23679084</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, et al. Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat. Neuromuscul Disord. 2014;24(11):978&#x2013;981. doi: 10.1016/j.nmd.2014.06.441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2014.06.441</ArticleId><ArticleId IdType="pmc">PMC4252652</ArticleId><ArticleId IdType="pubmed">25047668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambon C, et al. Myocytic androgen receptor controls the strength but not the mass of limb muscles. Proc Natl Acad Sci U S A. 2010;107(32):14327&#x2013;14332. doi: 10.1073/pnas.1009536107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009536107</ArticleId><ArticleId IdType="pmc">PMC2922552</ArticleId><ArticleId IdType="pubmed">20660752</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest. 2006;116(10):2663&#x2013;2672. doi: 10.1172/JCI28773..</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773.</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Miniou P, et al. Gene targeting restricted to mouse striated muscle lineage. Nucleic Acids Res. 1999;27(19):e27. doi: 10.1093/nar/27.19.e27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/27.19.e27</ArticleId><ArticleId IdType="pmc">PMC148637</ArticleId><ArticleId IdType="pubmed">10481039</ArticleId></ArticleIdList></Reference><Reference><Citation>Madisen L, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13(1):133&#x2013;140. doi: 10.1038/nn.2467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2467</ArticleId><ArticleId IdType="pmc">PMC2840225</ArticleId><ArticleId IdType="pubmed">20023653</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco AF et al. (2021) Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7. Dis Model Mech 14(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8319550</ArticleId><ArticleId IdType="pubmed">34160002</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>